Literature DB >> 2241521

Practice guidelines and outcomes. Where are we headed?

D B Nash1.   

Abstract

Major forces are at work within the health care system that drive the development of clinical standards or guidelines. This process must be tied in a "feedback-loop" system to a more accurate assessment of patient outcomes. There is a major controversy at the foundation of the process that is pitting the opinions from consensus panels of experts against the inability of individual physicians to accurately estimate the outcomes of different options through implicit systems. In many instances, the quality of medical evidence is poor. Many groups within organized medicine are attempting to write guidelines, and at least four major challenges must be confronted before guidelines are widely adopted by clinicians. A new federal agency may provide the necessary resources to focus the debate on guidelines. Guidelines may eventually enhance the quality of medical care.

Entities:  

Mesh:

Year:  1990        PMID: 2241521

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  The formulary decision-making process in a US academic medical centre.

Authors:  D B Nash; M L Catalano; C J Wordell
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

2.  Investigations: how to get from guidelines to protocols.

Authors:  D Jenkins
Journal:  BMJ       Date:  1991-08-10

3.  Online practice guidelines: issues, obstacles, and future prospects.

Authors:  R D Zielstorff
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

Review 4.  Research trends in evidence-based medicine: a joinpoint regression analysis of more than 50 years of publication data.

Authors:  Bui The Hung; Nguyen Phuoc Long; Le Phi Hung; Nguyen Thien Luan; Nguyen Hoang Anh; Tran Diem Nghi; Mai Van Hieu; Nguyen Thi Huyen Trang; Herizo Fabien Rafidinarivo; Nguyen Ky Anh; David Hawkes; Nguyen Tien Huy; Kenji Hirayama
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.